Procera® Crown Zirconia 0.4 â strength combined ... - Nobel Biocare
Procera® Crown Zirconia 0.4 â strength combined ... - Nobel Biocare
Procera® Crown Zirconia 0.4 â strength combined ... - Nobel Biocare
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Procera® <strong>Crown</strong> <strong>Zirconia</strong> <strong>0.4</strong> –<br />
<strong>strength</strong> <strong>combined</strong> with better esthetics<br />
<strong>Nobel</strong> <strong>Biocare</strong>’s Procera® System is renowned for producing all-ceramic products with<br />
exceptional marginal fit, <strong>strength</strong>, and excellent esthetic qualities. In response to its<br />
customers’ needs, <strong>Nobel</strong> <strong>Biocare</strong> is now introducing a product that will enable laboratories<br />
more flexibility in their porcelain applications – Procera® <strong>Crown</strong> <strong>Zirconia</strong> <strong>0.4</strong>.<br />
Based on the well-received Procera® <strong>Crown</strong> <strong>Zirconia</strong>, this <strong>0.4</strong>mm thick coping version will<br />
allow for greater porcelain buildup.<br />
The Procera® <strong>Crown</strong> <strong>Zirconia</strong> <strong>0.4</strong> still features market-leading flexural <strong>strength</strong> of 1200MPa,<br />
translucency and metal-free material that enable its use in all indications, but now offers<br />
even better esthetics in the anterior region.<br />
For more information, visit: www.nobelbiocare.com<br />
Scientific evidence<br />
Zitzmann N, Galindo M, Hagmann E, Marinello C. Clinical evaluation of Procera AllCeram <strong>Crown</strong>s in the anterior and<br />
posterior regions. Int J Prosthodont 2007;20:239-41.<br />
Goodacre et.al. Clinical complications in fixed prosthodontics. Goodacre et.al. J Prosthet Dent 2003;90(1):31-41.<br />
Ödman P, Andersson B. Procera® AllCeram crowns followed for 5 to 10.5 years: a prospective clinical study. Int J<br />
Prosthodont 2001 Nov-Dec;14(6):504-9.<br />
Sierraalta M, Odén A, Razzoog ME. Material <strong>strength</strong> of zirconia produced with two methods. J Dent Res 2003;82 (Spec Iss<br />
A): abstract # 0450.<br />
May KB, Russell MM, Razzoog ME, Lang BR. Precision of fit: the Procera® AllCeram crown. J Prosthet Dent<br />
1998;80(4):394-404.<br />
Quintas AF, Oliveira F, Bottino MA.Vertical marginal discrepancy of ceramic copings with different ceramic materials, finish<br />
lines, and luting agents: an in vitro evaluation. J Prosthet Dent 2004 Sep;92(3):250-7.<br />
NOBEL BIOCARE HOLDING AG<br />
For further press information, please contact:<br />
Mikael Lagerqvist, PR & Media Planner Manager<br />
Tel +46 31 778 87 12<br />
Cell +46 768 788 712<br />
E-mail mikael.lagerqvist@nobelbiocare.com<br />
<strong>Nobel</strong> <strong>Biocare</strong> is a medical devices group and the world leader in innovative esthetic dental<br />
solutions with its brands Brånemark System ® , <strong>Nobel</strong>Replace, <strong>Nobel</strong>Speedy, <strong>Nobel</strong>Perfect ® ,<br />
<strong>Nobel</strong>Direct ® , Replace Select, (dental implants), Procera ® (individualized dental prosthetics),<br />
<strong>Nobel</strong>Guide (complete patient rehabilitation program) and <strong>Nobel</strong>Smile (patient education<br />
website). <strong>Nobel</strong> <strong>Biocare</strong> is a one-stop shop for restorative esthetic dentistry, offering a wide range of<br />
innovative <strong>Crown</strong> & Bridge & Implant products, as well as training and education, patient information<br />
and clinically documented treatment concepts. <strong>Nobel</strong> <strong>Biocare</strong> has over 2,100 employees and<br />
recorded revenue of EUR 601 million in 2006. The Company is domiciled in Zurich, Switzerland with<br />
headquarters in Zurich and in Gothenburg, Sweden. Production takes place at four production sites<br />
located in Sweden and the USA. <strong>Nobel</strong> <strong>Biocare</strong> has direct sales organizations in 34 countries. The<br />
shares of the parent company <strong>Nobel</strong> <strong>Biocare</strong> Holding AG are listed on the SWX Swiss Exchange and<br />
on the Stockholm Stock Exchange, Sweden.<br />
www.nobelbiocare.com<br />
1 (2)
Procera® <strong>Crown</strong> <strong>Zirconia</strong> 4.0<br />
2 (2)
Change language